<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for AKRX</title>
    <link />
    <description>Headlines for Akorn, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Akorn's CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1409921-akorn-s-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 07 May 2013 14:41:07 GMT</pubDate>
    </item>
    <item>
      <title>Why Akorn Shares Were Crushed</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/07/why-akorn-shares-were-crushed/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 07 May 2013 13:24:00 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Day Market Update: Fossil Gains On Q1 Results, Aruba Networks Falls</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/05/3566701/mid-day-market-update-fossil-gains-on-q1-results-aruba-networks-falls.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 07 May 2013 12:22:14 GMT</pubDate>
    </item>
    <item>
      <title>AKRX Crosses Below Key Moving Average Level</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11916190/1/akrx-crosses-below-key-moving-average-level.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 07 May 2013 11:32:00 GMT</pubDate>
    </item>
    <item>
      <title>Mid-Morning Market Update: Markets Surge, Emerson Electric Lowers View</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/05/3566255/mid-morning-market-update-markets-surge-emerson-electric-lowers-view.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Tue, 07 May 2013 10:56:28 GMT</pubDate>
    </item>
    <item>
      <title>Akorn Reports First Quarter 2013 Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/07/akorn-reports-first-quarter-2013-financial-results/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 07 May 2013 06:19:09 GMT</pubDate>
    </item>
    <item>
      <title>Orphan Drug Status for Teva/Xenon Drug - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98089/orphan-drug-status-for-teva-xenon-drug.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 26 Apr 2013 15:44:01 GMT</pubDate>
    </item>
    <item>
      <title>Favorable Court Ruling for Actavis - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97518/favorable-court-ruling-for-actavis.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 19 Apr 2013 17:45:01 GMT</pubDate>
    </item>
    <item>
      <title>Data on Teva's Milprosa - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97405/data-on-tevas-milprosa.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 18 Apr 2013 18:20:01 GMT</pubDate>
    </item>
    <item>
      <title>Still Neutral on Mylan - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97093/still-neutral-on-mylan.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 15 Apr 2013 17:20:01 GMT</pubDate>
    </item>
    <item>
      <title>Dr. Reddy's Launches Generic Reclast - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96352/dr-reddys-launches-generic-reclast.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 04 Apr 2013 19:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Another Generic Launch at Mylan - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96317/another-generic-launch-at-mylan.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Thu, 04 Apr 2013 14:36:01 GMT</pubDate>
    </item>
    <item>
      <title>KaloBios Pharma Incurs Wider Loss - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96203/kalobios-pharma-incurs-wider-loss.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Wed, 03 Apr 2013 12:24:01 GMT</pubDate>
    </item>
    <item>
      <title>Dr. Reddy's Launches Generic Accutane - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/96000/dr-reddys-launches-generic-accutane.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 01 Apr 2013 16:17:01 GMT</pubDate>
    </item>
    <item>
      <title>Data on Teva's Azilect  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/95619/data-on-tevas-azilect.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 25 Mar 2013 18:50:01 GMT</pubDate>
    </item>
    <item>
      <title>Top 4 Stocks In The Drugs-Generic Industry With The Highest Profit Margin</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/13/03/3419327/top-4-stocks-in-the-drugs-generic-industry-with-the-highest-profit-margi.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 15 Mar 2013 04:56:17 GMT</pubDate>
    </item>
    <item>
      <title>A Quick Look At 8 Biotechs Ready To Gain Momentum</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1263951-a-quick-look-at-8-biotechs-ready-to-gain-momentum.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 11 Mar 2013 15:44:16 GMT</pubDate>
    </item>
    <item>
      <title>3 Earnings Reports That Caught My Attention Last Week</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/04/3-earnings-reports-that-caught-my-attention-las-19/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Mon, 04 Mar 2013 09:46:00 GMT</pubDate>
    </item>
    <item>
      <title>Akorn's CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1225811-akorn-s-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 26 Feb 2013 14:58:03 GMT</pubDate>
    </item>
    <item>
      <title>Akorn Reports 2012 Fourth Quarter and Year-End Financial Results</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/26/akorn-reports-2012-fourth-quarter-and-year-end-fin/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 26 Feb 2013 07:36:46 GMT</pubDate>
    </item>
  </channel>
</rss>
